Whyte MB, Hinton W, McGovern A, et al. - Researchers examined if glycaemic control, monitoring, and prescribing differ among people with T2D. Using the Royal College of General Practitioners Research and Surveillance Centre dataset, they studied diabetes healthcare provision and glucose-lowering medication use between 1 January 2012 and 31 December 2016 in a cohort of 84,452 (5.29%) adults with T2D. The analysis revealed the existence of disparities in glycaemic control and the use of more recently introduced medications for glycaemic control in ethnic minority groups. Over the study period, continuous monitoring for diabetes complications was less frequent among socioeconomically disadvantaged individuals, as well as those of Black ethnicity. This emphasizes the necessity to ascertain if these disparities represent inequality in care.